The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banknote cleaning system also deactivates Covid-19

21 Jul 2021 07:00

RNS Number : 8955F
Spectra Systems Corporation
21 July 2021
 

Spectra Systems Corporation

("Spectra")

 Banknote cleaning system also deactivates Covid-19

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, is pleased to announce that tests conducted at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) have shown that Spectra's Aeris banknote cleaning process also deactivates SARS-2 below detectable limits during the one hour cleaning cycle. The results, performed in a Biosafety Level IV facility were obtained for straps of Canadian polymer banknotes as well as USA dollar and Indian Rupee banknotes. These new SARS-2 results are in addition to previous data that showed that Aeris, in addition to cleaning banknotes and reducing replacement costs, also disinfected banknotes from other pathogens including enteroviruses and bacteria.

When Covid-19 was emerging as a pandemic, a multitude of central banks expressed interest in whether Aeris could both remove soiling as well as deactivate SARS-2. This new data makes Aeris valuable both for saving banknote replacement costs as well as for increasing the safety of cash.

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We are pleased that our collaboration with Boston University's National Emerging Infectious Diseases Laboratories has produced results that bring a new value proposition for our Aeris technology. With the new SARS-2 Delta variant producing spikes of new cases in the UK and worldwide, we are proud to be the company that is facing this head on with solutions that not only save taxpayers money, but also increase their public health safety. The company believes that Aeris, in addition to our newest patented technology for disinfecting banknotes using heat and oxygen-free environment makes us the only company in the world with proven solutions for central banks, commercial banks and casinos."

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding, Managing Director, Corporate Finance Tel: +44 (0) 20 7220 1650 

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBLFLFDLLBBV
Date   Source Headline
6th Mar 20097:38 amRNSNet Asset Value(s)
5th Mar 20098:31 amRNSNet Asset Value(s)
4th Mar 20097:39 amRNSNet Asset Value(s)
3rd Mar 20097:47 amRNSNet Asset Value(s)
2nd Mar 20097:42 amRNSNet Asset Value(s)
27th Feb 20097:37 amRNSNet Asset Value(s)
26th Feb 20097:40 amRNSNet Asset Value(s)
25th Feb 20097:43 amRNSNet Asset Value(s)
24th Feb 20097:42 amRNSNet Asset Value(s)
23rd Feb 20097:41 amRNSNet Asset Value(s)
20th Feb 20097:40 amRNSNet Asset Value(s)
19th Feb 20097:47 amRNSNet Asset Value(s)
18th Feb 20098:04 amRNSNet Asset Value(s)
16th Feb 20097:58 amRNSNet Asset Value(s)
13th Feb 20097:56 amRNSNet Asset Value(s)
12th Feb 20097:44 amRNSNet Asset Value(s)
11th Feb 20097:33 amRNSNet Asset Value(s)
10th Feb 20097:45 amRNSNet Asset Value(s)
9th Feb 20097:51 amRNSNet Asset Value(s)
6th Feb 20097:39 amRNSNet Asset Value(s)
5th Feb 20097:41 amRNSNet Asset Value(s)
4th Feb 20097:44 amRNSNet Asset Value(s)
3rd Feb 20097:43 amRNSNet Asset Value(s)
2nd Feb 20097:49 amRNSNet Asset Value(s)
30th Jan 20097:44 amRNSNet Asset Value(s)
29th Jan 20097:55 amRNSNet Asset Value(s)
28th Jan 20097:45 amRNSNet Asset Value(s)
27th Jan 20097:51 amRNSNet Asset Value(s)
26th Jan 20098:09 amRNSNet Asset Value(s)
23rd Jan 20097:43 amRNSNet Asset Value(s)
22nd Jan 20097:44 amRNSNet Asset Value(s)
21st Jan 20097:50 amRNSNet Asset Value(s)
19th Jan 20097:54 amRNSNet Asset Value(s)
16th Jan 20098:05 amRNSNet Asset Value(s)
15th Jan 20097:44 amRNSNet Asset Value(s)
14th Jan 20097:47 amRNSNet Asset Value(s)
13th Jan 20097:40 amRNSNet Asset Value(s)
12th Jan 20097:44 amRNSNet Asset Value(s)
9th Jan 20097:41 amRNSNet Asset Value(s)
8th Jan 20097:49 amRNSNet Asset Value(s)
7th Jan 20097:43 amRNSNet Asset Value(s)
6th Jan 20097:47 amRNSNet Asset Value(s)
5th Jan 20097:41 amRNSNet Asset Value(s)
2nd Jan 20097:43 amRNSNet Asset Value(s)
31st Dec 20087:44 amRNSNet Asset Value(s)
30th Dec 20087:53 amRNSNet Asset Value(s)
29th Dec 20088:44 amRNSNet Asset Value(s)
24th Dec 20087:45 amRNSNet Asset Value(s)
23rd Dec 20087:41 amRNSNet Asset Value(s)
22nd Dec 20088:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.